Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Invest in Health Equity or Healthcare Will Fail

A lack of health insurance can be detrimental to anyone if there is any medical emergency or accident that occurs in that span of time. Healthcare costs are high even with insurance. Without insurance? Astronomical and simply unaffordable for many. So, it should come as a concern that in 2021, 8.6 percent of Americans did…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Invest in Health Equity or Healthcare Will Fail

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

A lack of health insurance can be detrimental to anyone if there is any medical emergency or accident that occurs in that span of time. Healthcare costs are high even with insurance. Without insurance? Astronomical and simply unaffordable for many. So, it should come as a concern that in 2021, 8.6 percent of Americans did not have health insurance. That’s almost one in every ten people.

What needs to be done today to improve health equity and ensure everyone has access to appropriate medical care and services?

On today’s episode of Healthcare Rethink, Host Brian Urban speaks with Dr. David Nash, Founding Dean Emeritus, Jefferson College of Population Health, Dr. David Ansell, Senior VP for Community Health Equity at Rush University Medical Center, and Dr. Omar Lateef, President and CEO, Rush University Medical Center, to discuss how health equity has gained traction since the COVID-19 pandemic, what consequences inequalities in health access create, and what changes have been stirring the past few years to address this gap.

The group also discussed…

  1. Lateef’s 2021 investment in health equity education, workforce development, community-based clinical practice, and health equity research
  2. How the Jefferson College of Population Health is creating health equity-conscious doctors, nurses, and pharmacists as leaders
  3. How the health equity institute partnership with Vimo will facilitate meeting basic needs of individuals in the U.S. through its work

Dr. Lateef explained how COVID-19 has highlighted the importance of health equity. “All of a sudden, it seems to folks like Ansell and Nash that the world is finally understanding how important it is to have equitable access to care, access to procedures, access to primary care doctors, access to safe border, food, all the rest, and the amazing impact that all of these factors have on health.”

“So, we created, with a generous donation from Vimo Financial, a health equity institute that’s not only about solving the problem, but training the next generation of healthcare leaders who will help solve the problem as well,” Dr. Ansell added.

Dr. Nash brought up Jefferson College of Population Health is facilitating adoption of health equity in their curriculum for tomorrow’s health leaders.

“The mission of the school is to continue to build a different type of leader for the future, where the issues that Dr. Ansell and Dr. Lateef described about the social determinants of health, racial discrimination, putting these issues deeper into the medical curriculum nursing curriculum, and pharmacy curriculum. And we do that in all kinds of ways. Online master’s degrees…building relationships with many other schools, research in this area, our scholarly peer-reviewed journal, our annual conference, my book…this is a generational issue which were not going to fix tomorrow, but we now have more than a decade of helping to create a different kind of leader for whom these issues are a core part of their training,” he stated.

Dr. David Nash is Founding Dean Emeritus of Jefferson College of Population Health and Dr. Raymond C. and Doris N. Grandon Professor of Medicine at Thomas Jefferson University. He has a BA in Economics from Vassar College, an MD from the University of Rochester School of Medicine and Dentistry, and an MBA from The Wharton School. Dr. Nash is a board-certified internist, has held a variety of governance positions, and has earned a multitude of accolades such as the Philadelphia Business Journal Healthcare Heroes Award and honorary distinguished fellow of the American College of Physician Executives.

Dr. David Ansell is Senior VP for Community Health Equity at Rush University Medical Center and was the first Chief Medical Officer there while serving as associate dean and senior vice president for clinical affairs. Prior to working at Rush, Dr. Ansell was chairperson of the Department of Internal Medicine at Chicago’s Mount Sinai Hospital. He co-founded the Sinai Urban Health Institute, helped establish the nonprofit Metropolitan Chicago Breast Cancer Taskforce, and helped create the Center for Community Health Equity in Chicago. Dr. Ansell is a two-time author and earned his BS from Franklin and Marshall College and his doctoral degree from SUNY Upstate Medical University as well as a master’s degree in public health from the University of Illinois.

Dr. Omar Lateef is President and CEO of Rush Medical University Center and was previously Chief Medical Officer. He is a 2021 recipient of the Mayor’s Medal of Honor in Chicago and has assisted the U.S. Department of Health and Human Services by serving on the National Advisory Council for Healthcare Research and Quality of the Agency for Healthcare Research and Quality. Dr. Lateef’s BS is from the University of Florida-Gainesville and his medical degree is from Des Moines University. Dr. Lateef completed his residency at NYU Downtown Hospital and his fellowship in pulmonary and critical care medicine at Rush University Medical Center.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512